The Functional and Emotional Benefits of Replenix Power of Three With Resveratrol
NCT03563365 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 43
Last updated 2021-04-23
Summary
A Randomized, Investigator Blinded, Single Site, Three Arm Clinical Study to Assess the Functional and Emotional Benefits of Replenix Power of Three Cream with Resveratrol , Replenix Power of Three Cream with Resveratrol with Adapalene and Benzoyl Peroxide Gel, 0.1%/2.5%, and Adapalene and Benzoyl Peroxide Gel, 0.1%/2.5%, utilized to treat subjects with Facial Acne Vulgaris
Conditions
- Acne Vulgaris
Interventions
- OTHER
-
Replenix Power of 3 Cream with resveratrol
Cosmetic product containing Green Tea Polyphenols, Resveratrol, Caffeine USP, Bisabolol Cucumber extract, Chamomile extract, Rosemary extract, Squalane, Soy Phospholipids
- DRUG
-
Adapalene and Benzoyl peroxide gel, 0.1%/2.5%
FDA approved topical agent for the treatment of acne
Sponsors & Collaborators
-
Topix Pharmaceuticals, Inc
collaborator UNKNOWN -
Yardley Dermatology Associates
lead OTHER
Principal Investigators
-
Richard G Fried, MD, PhD · Yardley Dermatology Associates, PC
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- FACTORIAL
Eligibility
- Min Age
- 12 Years
- Max Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-06-04
- Primary Completion
- 2021-03-02
- Completion
- 2021-03-02
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
A Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris
NCT00421993 ·Status: COMPLETED ·Phase: PHASE3
-
Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris
NCT03650361 ·Status: COMPLETED ·Phase: PHASE3
-
Adapalene-Benzoy Peroxide (BPO) Gel in the Treatment of Acne Vulgaris as a 6-month Maintenance
NCT00687908 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Fixed Combination Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris
NCT00441415 ·Status: COMPLETED ·Phase: PHASE3
-
Open-Label, Randomized Study Evaluating the Absorption and Systemic Pharmacokinetics of Topically Applied IDP-126 Gel in Comparison With Control Gel
NCT03653403 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Assessing the Efficacy of Combined Use of Clascoterone 1% Cream and Adapalene 0.3% for the Treatment of Acne
NCT06336603 ·Status: COMPLETED ·Phase: PHASE4
-
Two-week Study to Compare the Tolerance and Irritation Potential of Two Combination Topical Gel Acne Medications
NCT00926367 ·Status: COMPLETED ·Phase: PHASE4
-
Long-term Study of Efficacy/Safety of Adapalene/Benzoyl Peroxide Topical Gel in Acne Vulgaris Subjects
NCT00446043 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris
NCT03003247 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of Subjects' Efficacy and Experiences Using Adapalene BPO Gel in the Treatment of Acne Vulgaris
NCT01209949 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris
NCT02965456 ·Status: COMPLETED ·Phase: PHASE3
-
"A Comparative Clinical Evaluation of the Efficacy of Topical Adapalene, Benzoyl Peroxide Gel, Oral Lactobacillus Rhamnosus, D-chiro-inositol, Inulin Capsule, and Their Fixed Combination in Mild to Moderate Acne Vulgaris Patients."
NCT05855629 ·Status: UNKNOWN ·Phase: NA
-
Adapalene Gel 0.3% Versus Tretinoin 0.05% Emollient Cream for Treatment of Photodamage
NCT00647556 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Comparing Adapalene Gel 0.1% and to Differin Gel in the Treatment of Acne Vulgaris
NCT04797793 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Study Comparing Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% to Epiduo® and Both to a Placebo Control in the Treatment of Acne Vulgaris
NCT01742637 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Irritation by Two Facial Gels Applied to Opposite Sides of the Face
NCT00919191 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris
NCT02932306 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Comparing Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2% (Taro Pharmaceuticals U.S.A., Inc.) and CABTREO Topical Gel for the Treatment of Acne Vulgaris.
NCT06673641 ·Status: COMPLETED ·Phase: PHASE1
-
Study Comparing 0.3% Adapalene Topical Gel to Differin® 0.3% Adapalene Topical Gel
NCT01095640 ·Status: COMPLETED ·Phase: NA
-
Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris
NCT03664739 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Endpoint Bioequivalence Study of Adapalene Gel 0.1%
NCT04329403 ·Status: WITHDRAWN ·Phase: PHASE3
-
Study to Determine and Compare the Tolerance and Irritation Potential of Topical Acne Medications
NCT00964366 ·Status: COMPLETED ·Phase: PHASE4
-
Study Comparing Adapalene Gel 0.3% to Differin® and Both to a Placebo Control in Treatment of Acne Vulgaris
NCT02411942 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris
NCT04214639 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Study to Evaluate the Tolerability of a Topical Antibiotic and Retinoid Used in a Combined Regimen With a BPO Wash
NCT00891982 ·Status: COMPLETED ·Phase: PHASE3